Tuberculosis Test Usage and Medical Expenditures from Outpatient Insurance Claims Data, 2013

by Kwame Owusu-Edusei, Carla A. Winston, Suzanne M. Marks, Adam J. Langer, Roque Miramontes
Published 2017-01-01

Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness.

by Nwabunie Nwana, Suzanne M Marks, Edward Lan, Alicia H Chang, Michael Holcombe, Sapna Bamrah Morris
Published 2019-01-01

Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis

by Andrea Parriott, Mohsen Malekinejad, Amanda P. Miller, Suzanne M. Marks, Hacsi Horvath, James G. Kahn
Published 2018-04-01

Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review.

by Andrea Parriott, Mohsen Malekinejad, Amanda P Miller, Hacsi Horvath, Suzanne M Marks, James G Kahn
Published 2018-01-01

Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review.

by Mohsen Malekinejad, Andrea Parriott, Amanda P Viitanen, Hacsi Horvath, Suzanne M Marks, James G Kahn
Published 2017-01-01

Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review.

by Amanda P Miller, Mohsen Malekinejad, Hacsi Horváth, Janet C Blodgett, James G Kahn, Suzanne M Marks
Published 2019-01-01

Opportunities for tuberculosis diagnosis and prevention among persons living with HIV: a cross-sectional study of policies and practices at four large Ryan White Program-Funded HIV...

by Lisa Pascopella, Julie Franks, Suzanne M Marks, Katya Salcedo, Kjersti Schmitz, Paul W Colson, Yael Hirsch-Moverman, Jennifer Flood, Jennifer Sayles
Published 2014-01-01

State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.

by Ali Mirzazadeh, James G Kahn, Maryam B Haddad, Andrew N Hill, Suzanne M Marks, Adam Readhead, Pennan M Barry, Jennifer Flood, Jonathan H Mermin, Priya B Shete
Published 2021-01-01

Outlook for tuberculosis elimination in California: An individual-based stochastic model.

by Alex J Goodell, Priya B Shete, Rick Vreman, Devon McCabe, Travis C Porco, Pennan M Barry, Jennifer Flood, Suzanne M Marks, Andrew Hill, Adithya Cattamanchi, James G Kahn
Published 2019-01-01

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007

by Suzanne M. Marks, Jennifer Flood, Barbara Seaworth, Yael Hirsch-Moverman, Lori Armstrong, Sundari Mase, Katya Salcedo, Peter Oh, Edward A. Graviss, Paul W. Colson, Lisa Armitige, Manuel Revuelta, Kathryn Sheeran
Published 2014-05-01